In a previous article, we have talked about how dementia is diagnosed, its symptoms and consequences, the importance of doing it with the right professional, and the toll that it could have in family members and care partners. Making an accurate and timely diagnosis of dementia is a first step in a long journey that will last years and will require support for the person living … [Read more...] about Post-diagnostic Management of Dementia, a Prescription of Care
Uncategorized
Aging at home: the preferred option of older adults
People prefer to age at home, in a familiar setting, and surrounded, when possible, by their belongings and closest relatives and friends. This is not only a matter of personal preference. The World Health Organization highlights the importance of the context in determining the effects of aging on health: aging at home increases confidence levels, independence, and … [Read more...] about Aging at home: the preferred option of older adults
We invite you to see the material of our Regional Policy Dialogue 2019: A regional debate on long-term care systems
On November 12 and 13, we conducted the Regional Policy Dialogue of the Social Protection and Health Division of the IDB, which this year was on the Pillars of Long-term Care: How to Build a System for Latin America and the Caribbean. This is an annual event that seeks to discuss the pressing issues of the region and generate an exchange between specialists, government … [Read more...] about We invite you to see the material of our Regional Policy Dialogue 2019: A regional debate on long-term care systems
Three Impacts of Digital Health on Healthcare
A young woman in Mexico with Type II diabetes hears her phone buzz and sees a notification – “Rise in blood sugar detected – inject 6 units of rapid acting insulin now.” … [Read more...] about Three Impacts of Digital Health on Healthcare
Would a Regional Regulatory Agency for Health Technologies be Feasible?
Regulatory agencies around the world are continuously reviewing requests for the commercialization of new medicines and other health technologies in their countries. With globalization, technological advances and innovation, and the emergence of new types of treatments, such as biologicals, biosimilars, and cell and gene therapies, the volume and complexity of such requests … [Read more...] about Would a Regional Regulatory Agency for Health Technologies be Feasible?